Role of microRNAs in kidney homeostasis and disease

Slides:



Advertisements
Similar presentations
Table II. Glossary of genes (Part 1).
Advertisements

Volume 64, Issue 1, Pages (July 2003)
Volume 76, Issue 9, Pages (November 2009)
Volume 70, Issue 10, Pages (November 2006)
Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
The complex world of kidney microRNAs
Volume 82, Issue 1, Pages 7-8 (July 2012)
Viper venom for diabetic nephropathy
Frederic Rahbari-Oskoui, MD, MS  American Journal of Kidney Diseases 
RNA interference in biology and disease
Regulation of mesangial cell proliferation
NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner  Hans-Joachim Anders, Maciej.
The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease
Role of HIPK2 in kidney fibrosis
Obstructive nephropathy: Insights from genetically engineered animals
Ding Ai, John Y.-J. Shyy, Yi Zhu  Kidney International 
Regulating Cancer Stem Cells the miR Way
Rafael Kramann, Marcus J. Moeller  Kidney International 
Viper venom for diabetic nephropathy
Volume 84, Issue 6, Pages (December 2013)
Renoprotective effects of vitamin D analogs
Volume 85, Issue 3, Pages (March 2014)
Volume 76, Issue 9, Pages (November 2009)
Wnt/β-catenin signaling and kidney fibrosis
Comorbidity and confounding in end-stage renal disease
Volume 87, Issue 2, Pages (February 2015)
Gregory B. Vanden Heuvel  Kidney International 
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Volume 82, Issue 8, Pages (October 2012)
The renin–angiotensin–aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?  Sharon J. Nessim, Jeffrey.
Volume 73, Issue 1, Pages 5-7 (January 2008)
Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,
Volume 116, Issue 2, Pages (January 2004)
Nirupama Ramkumar, Donald E. Kohan  Kidney International 
Volume 70, Issue 10, Pages (November 2006)
Claudine S. Bonder, Lisa M. Ebert  Kidney International 
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Osteopontin in diabetic nephropathy: signpost or road?
Nitric oxide and vascular remodeling: Spotlight on the kidney
The promise of biomarkers for personalized renal cancer care
David M. Charytan, John P. Forman  Kidney International 
Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen  David I. Ortiz-Melo, Robert F. Spurney 
It takes two to Twist Kidney International
The future of renoprotection: Frustration and promises
Urinary biomarkers: the future looks promising
Volume 74, Issue 8, Pages (October 2008)
Twist: a new link from hypoxia to fibrosis
Atrial fibrillation in end-stage renal disease: an emerging problem
Volume 56, Issue 4, Pages (October 1999)
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Juan Camilo Duque, Roberto I. Vazquez-Padron  Kidney International 
The Duality of Angiogenesis: Implications for Therapy of Human Disease
It's not over till the last glomerulus forms
Volume 82, Issue 9, Pages (November 2012)
Guang-Huar Young, Vin-Cent Wu  Kidney International 
Markus Bitzer, Iddo Z. Ben-Dov, Thomas Thum  Kidney International 
Engineering parathyroid cells to treat secondary hyperparathyroidism
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 76, Issue 5, Pages (September 2009)
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Volume 56, Issue 6, Pages (December 1999)
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 6, Pages (March 2009)
Volume 74, Issue 10, Pages (November 2008)
Volume 75, Issue 8, Pages (April 2009)
Can we cure HIV-1-associated nephropathy in transgenic mice?
Proteinuria and hypertension with tyrosine kinase inhibitors
Presentation transcript:

Role of microRNAs in kidney homeostasis and disease Karthikeyan Chandrasekaran, Dwi S. Karolina, Sugunavathi Sepramaniam, Arunmozhiarasi Armugam, E. Marelyn Wintour, John F. Bertram, Kandiah Jeyaseelan  Kidney International  Volume 81, Issue 7, Pages 617-627 (April 2012) DOI: 10.1038/ki.2011.448 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 MicroRNA (miRNA)—biogenesis and function. The biosynthesis of miRNAs, as well as their activity in translational repression (RNA interference (RNAi)) and transcriptional modulation (RNAa or RNAi), is represented diagrammatically. Pre-miRNA, precursor miRNA; RISC, RNA-induced silencing complex; RNAa, RNA activation. Kidney International 2012 81, 617-627DOI: (10.1038/ki.2011.448) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Nephron with relevant channels and microRNAs (miRNAs). Structure of nephron and the number of miRNAs predicted to be involved in kidney function and homeostasis are shown. The numerical values in brackets represent the total numbers of miRNAs predicted in each nephron segment by bioinformatic analysis on five databases (miRwalk, miRanda, miRDB, RNA22, TargetScan/TargetScanS). ACE, angiotensin; AGT, angiotensinogen; ANG, angiotensin-converting enzyme; AQP, aquaporin; REN, renin genes. Kidney International 2012 81, 617-627DOI: (10.1038/ki.2011.448) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 3 MicroRNAs (miR) in renal diseases. Possible miRNA-regulatory networks involved in renal pathophysiology as described in text are shown. Col1, collagen type 1; ECM, extracellular matrix; δEFI, delta 1–crystallin enhancer binding protein; EMT, epithelial–mesenchymal transition; Ig, immunoglobulin; Itgb1, integrin beta 1; miRNA, microRNA; MMP2, matrix metalloproteinase 2; mnSOD, manganese superoxide dismutase; PI3K, phosphoinositide kinase-3; PKD, polycyctic kidney disease; PTEN, phosphatase and tensin homolog; SIP1, smad-interacting protein; TGF-β, transforming growth factor beta; VEGF, vascular endothelial growth factor; ZEB, zinc finger E-box-binding homeobox. Kidney International 2012 81, 617-627DOI: (10.1038/ki.2011.448) Copyright © 2012 International Society of Nephrology Terms and Conditions